LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.

    Vakil, Erik / Sheshadri, Ajay / Faiz, Saadia A / Shah, Dimpy P / Zhu, Yayuan / Li, Liang / Kmeid, Joumana / Azzi, Jacques / Balagani, Amulya / Bashoura, Lara / Ariza-Heredia, Ella / Chemaly, Roy F

    Transplant infectious disease : an official journal of the Transplantation Society

    2018  Volume 20, Issue 6, Page(s) e12994

    Abstract: Background: Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is ... associated with high mortality in patients with hematologic malignancies (HM). We sought to determine ... independent risk factors associated with 60-day all-cause mortality.: Results: Mortality was high in HM ...

    Abstract Background: Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is associated with high mortality in patients with hematologic malignancies (HM). We sought to determine whether allogeneic hematopoietic cell transplant (allo-HCT) recipients would be at higher risk for 60-day mortality.
    Methods: We examined a retrospective cohort of adults with HM with or without HCT treated for RSV LRTI (n = 154) at our institution from 1996-2013. We defined possible RSV LRTI as RSV detected only in the upper respiratory tract with new radiologic infiltrates and proven RSV LRTI as RSV detected in BAL fluid with new radiologic infiltrates. Immunodeficiency Scoring Index (ISI) and Severe Immunodeficiency (SID) criteria were calculated for HCT recipients. Multivariable logistic regression analyses were performed to identify independent risk factors associated with 60-day all-cause mortality.
    Results: Mortality was high in HM patients (25%), but there was no difference between those without HCT, autologous or allo-HCT recipients in logistic regression models. Separate multivariate models showed that at RSV diagnosis, neutropenia (OR 8.3, 95% CI 2.8-24.2, P = 0.005) and lymphopenia (OR 3.7, 95% CI 1.7-8.2, P = 0.001) were associated with 60-day mortality. Proven LRTI was associated with higher 60-day mortality (neutropenia model: OR 4.7, 95%CI 1.7-13.5; lymphopenia model: OR 3.3, 95% CI 1.2-8.8), and higher ICU admission. In HCT recipients, high ISI and very severe immunodeficiency by SID criteria were associated with higher 60-day all-cause mortality.
    Conclusions: Mortality is similarly high among HM patients without HCT and HCT recipients. High-grade immunodeficiency and detection of RSV from BAL fluid are associated with higher 60-day mortality.
    MeSH term(s) Adult ; Aged ; Bronchoalveolar Lavage Fluid/virology ; Bronchoscopy ; Female ; Hematologic Neoplasms/surgery ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Immunocompromised Host ; Immunosuppression/adverse effects ; Immunosuppression/methods ; Lymphopenia/blood ; Lymphopenia/immunology ; Lymphopenia/mortality ; Lymphopenia/virology ; Male ; Middle Aged ; Neutropenia/blood ; Neutropenia/immunology ; Neutropenia/mortality ; Neutropenia/virology ; Respiratory Syncytial Virus Infections/blood ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/mortality ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Viruses/isolation & purification ; Respiratory Tract Infections/blood ; Respiratory Tract Infections/immunology ; Respiratory Tract Infections/mortality ; Respiratory Tract Infections/virology ; Retrospective Studies ; Risk Factors ; Survival Rate ; Transplantation, Homologous/adverse effects ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2018-09-21
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.12994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.

    Sheshadri, Ajay / Karimipour, Mahtab / Vakil, Erik / Bashoura, Lara / Godoy, Myrna / Arain, Muhammad H / Evans, Scott E / Dickey, Burton F / Ost, David E / Chemaly, Roy F / Faiz, Saadia A

    Transplant infectious disease : an official journal of the Transplantation Society

    2019  Volume 21, Issue 4, Page(s) e13105

    Abstract: ... respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI). We measured radiologic severity to determine ... Background: Immunocompromised hematologic malignancy (HM) patients experience high mortality after ... immunodeficiency in HM patients helps predict 60-day mortality after RSV LRTI, mortality risk estimates can be ...

    Abstract Background: Immunocompromised hematologic malignancy (HM) patients experience high mortality after respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI). We measured radiologic severity to determine whether it could improve the performance of 60-day mortality models based only upon immunodeficiency severity.
    Methods: We studied 155 HM patients, including 84 hematopoietic cell transplant recipients, who developed RSV LRTI from 2001 to 2013. We measured immunodeficiency using lymphopenia (lymphocyte count <200 cells/mm
    Results: Forty-one patients died within 60 days of RSV LRTI. Severe immunodeficiency was associated with higher mortality. Peak-RSI (odds ratio [OR] 1.06/point, 95% confidence interval [CI] 1.04-1.08), and delta-RSI (OR 1.07/point, 95% CI 1.05-1.10) were associated with 60-day mortality after RSV LRTI, but not baseline-RSI. Addition of peak-RSI or delta-RSI to baseline immunodeficiency improved the discrimination, calibration, and explained variance (P < 0.001) of 60-day mortality models.
    Conclusions: Although baseline immunodeficiency in HM patients helps predict 60-day mortality after RSV LRTI, mortality risk estimates can be further refined by also measuring LRTI progression using RSI. RSI is well-suited as a marker of LRTI severity in RSV infection.
    MeSH term(s) Adult ; Aged ; Antiviral Agents/therapeutic use ; Female ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/virology ; Humans ; Immunocompromised Host ; Logistic Models ; Male ; Middle Aged ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/mortality ; Respiratory Tract Infections/virology ; Retrospective Studies ; Risk Factors ; Severity of Illness Index
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2019-05-28
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.13105
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top